Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...
Despite their frequency, many people misunderstand what a fever means, when it’s dangerous and how best to manage it. Here’s ...
Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom ...
Supporting lupus patients and advocates in Arizona.
The patient has a rash on her cheeks and nose with sparing of the nasolabial folds, in addition to involvement of the dorsal ...
With the lupus treatment landscape poised for a shake-up, Roche is hitting t | Early Monday, Roche announced that the FDA ...
Patients with lupus nephritis who received hydroxychloroquine demonstrated a significantly lower risk for glomerular ...
Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in improving mucocutaneous symptoms of cutaneous and systemic lupus, according to data ...
Elizabeth Rosser receives funding from the Medical Research Foundation, the Lister Institute for Preventive Medicine and the Kennedy Trust for Rheumatology Research. Actress, singer and makeup mogul ...
The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in ...
The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback